NCT00233545View on ClinicalTrials.gov

Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2007

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

miltefosine

DRUG

antimony

Trial Locations (1)

Unknown

Puesto de Salud, Campamento OSCAR,, Palos Blancos

All Listed Sponsors
lead

AB Foundation

OTHER

NCT00233545 - Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia | Biotech Hunter | Biotech Hunter